Slowing the Spread of Drug-Resistant Diseases Is Goal of New Research Area (IMAGE)
Caption
In the war between drugs and drug-resistant diseases, is the current strategy for medicating patients giving many drug-resistant diseases a big competitive advantage?, asks a research paper that will be published in the Proceedings of the National Academy of Sciences. The paper argues for new research efforts to discover effective ways for managing the evolution and slowing the spread of drug-resistant disease organisms. The research is led by Andrew Read, professor of biology and entomology and director of the Center for Infectious Disease Dynamics at Penn State University. The ultimate goal of this new research effort is to develop a new science-based model for drug-resistance management that will inform treatment guidelines for a wide variety of diseases that affect people, including malaria and other diseases caused by parasites, MRSA and other diseases caused by bacterial infections, AIDS and other diseases caused by viruses, and cancer. This colored 2005 scanning electron micrograph (SEM) shows numerous clumps of methicillin-resistant Staphylococcus aureus bacteria, commonly referred to by the acronym, MRSA; Magnified 2390x.
Credit
Janice Haney Carr/CDC/ Jeff Hageman, M.H.S.
Usage Restrictions
The image credit must be published along with the image.
License
Licensed content